{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Axillary Treatment in Breast Cancer Patients with Positive Sentinel Node Biopsy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This multicenter trial randomized 2,000 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with operable unifocal invasive breast cancer and clinically negative lymph nodes"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to either ALND or ART"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the sentinel node identification rate, measured at the time of surgery."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomization was centralized and stratified by institution."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "randomized 2,000 patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 1,953 eligible patients"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "the sentinel node identification rate was 97% (1,888/1,953)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: EORTC 10981-22023 AMAROS."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}